|
⚲
|
| Keyboard |
| Bisgaier Charles PhD
✚
|
|
|---|---|
| CIK # | 0001381030 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001381030] | |
| 4 | [0001381030] | |
| SC 13D | [0001381030] | |
| SC 13G | [0001381030] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Bisgaier Charles PhD | Gemphire Therapeutics Inc | [2019-08-02] |
| Bisgaier Charles PhD | Gemphire Therapeutics Inc | [2017-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bisgaier Charles PhD | |
| MetaVia Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MetaVia Inc GEMP
Common Stock
|
2019-07-24 | Grant | 100,000 | $0.00 | |
|
MetaVia Inc GEMP
Stock Option (right to buy) · derivative
|
2018-01-28 | Grant | 48,000 | $0.00 | |
|
MetaVia Inc GEMP
Common Stock
|
2017-07-31 | Option exercise | 4,474 | $1.34 | 5,995 |
|
MetaVia Inc GEMP
Employee Stock Option (right to buy) · derivative
|
2017-07-31 | Option exercise | 4,474 | $0.00 | |
|
MetaVia Inc GEMP
Common Stock
|
2016-08-10 | Buy | 51,750 | $10.00 | 517,500 |
|
MetaVia Inc GEMP
Series A Convertible Preferred Stock · derivative
|
2016-08-10 | Conversion | 59,561 | $0.00 | |
|
MetaVia Inc GEMP
Common Stock
|
2016-08-10 | Conversion | 19,228 | $6.71 | 129,020 |
|
MetaVia Inc GEMP
8% Convertible Subordinated Promissory Notes · derivative
|
2016-08-10 | Conversion | $0.00 | ||
|
MetaVia Inc GEMP
8% Convertible Subordinated Promissory Notes · derivative
|
2016-08-10 | Conversion | $0.00 | ||
|
MetaVia Inc GEMP
Common Stock
|
2016-08-10 | Other | 6,515 | $6.71 | 43,716 |
|
MetaVia Inc GEMP
Common Stock
|
2016-08-10 | Conversion | 16,144 | $6.71 | 108,326 |
|
MetaVia Inc GEMP
Common Stock
|
2016-08-10 | Conversion | 59,561 | ||
|
MetaVia Inc GEMP
Employee Stock Option (right to buy) · derivative
|
2016-08-04 | Grant | 150,000 | $0.00 |